Teleflex Incorporated
Financials
Valuation Metrics
Teleflex Incorporated's Market Cap is $6.19B. At end of 2025 it was $5.40B. Ranked #1236 of 3,112 in US market (top 40%), #829 of 1,667 on NYSE (top 50%), #77 of 206 in Health Care Equipment & Services (top 37%) by Market Cap.
Investment Metrics(as of 2026-08-03)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | $6.19B | US#1,236/3,112 Sec#77/206 |
| Revenue | $2.81B | US#1,279/3,112 Sec#76/206 |
| Net Income | $-1.01B | US—/3,112 Sec—/206 |
| Total Assets | $6.78B | US#1,215/3,112 Sec#54/206 |
| Net Assets | $3.08B | US#966/3,112 Sec#49/206 |
| Employees | 15,500 | US#446/3,112 Sec#43/206 |
| Value | ||
| P/B | 2.01x | US#1,188/3,112 Sec#67/206 |
| P/S | 2.20x | US#1,368/3,112 Sec#95/206 |
| FCF Yield | 4.03% | US#1,511/3,112 Sec#84/206 |
| Profitability | ||
| ROE | -32.71% | US#2,637/3,112 Sec#165/206 |
| ROA | -14.87% | US#2,720/3,112 Sec#165/206 |
| Op. Margin | 6.48% | US#1,927/3,112 Sec#98/206 |
| Revenue Growth | -21.75% | US#2,790/3,112 Sec#202/206 |
| Earnings Growth | -108.58% | US#2,101/3,112 Sec#105/206 |
| Financial Health | ||
| Debt Ratio | 119.91% | US#1,264/3,112 Sec#122/206 |
| Total Debt | $2.69B | US#973/3,112 Sec#46/206 |
| FCF | $249M | US#1,237/3,112 Sec#71/206 |
| Cash | $309M | US#1,402/3,112 Sec#77/206 |
| Current Ratio | 2.55x | US#971/3,112 Sec#97/206 |
| Dividend | ||
| Div. Yield | 0.97% | US#1,311/3,112 Sec#29/206 |
| Div. Growth | -0.44% | US—/3,112 Sec—/206 |
| Performance | ||
| 1Y Return | 21.30% | US#1,430/3,112 Sec#97/206 |
| 1M Return | 4.30% | US#1,034/3,112 Sec#82/206 |
| From 52W High | -3.08% | US#350/3,112 Sec#20/206 |
| 1Y MDD | -24.36% | US#990/3,112 Sec#23/206 |
| Trading | ||
| Volume | 867,905 shares | US#1,605/3,112 Sec#117/206 |
| Trading Value | $122M | US#790/3,112 Sec#63/206 |
| Per Share | ||
| EPS | $-20.47 | US—/3,112 Sec—/206 |
| BPS | $70.64 | US#217/3,112 Sec#16/206 |
Company Info
Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications in the United States, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company offers vascular and emergency medicine products comprising Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous bone access systems for the administration of intravenous therapies, measurement of blood pressure, and collection of blood samples; intraosseous access systems consisting of EZ-IO intraosseous vascular access systems, and Arrow FAST1 sternal intraosseous infusion systems; and hemostatic products, including external hemostats and trauma products under the QuikClot brand. It also provides interventional products, including various coronary catheters, structural heart support devices, and peripheral intervention products platforms; GuideLiner, Turnpike, and TrapLiner catheters; MANTA vascular closure devices and Arrow OnControl powered bone biopsy systems; and coronary and peripheral medical devices, such as drug-coated balloons, stents, and balloon catheters. In addition, the company offers surgical products, including metal and polymer ligating clips using manual and automatic applier system, fascial closure surgical systems used in laparoscopic surgical procedures, percutaneous surgical systems, powered bariatric staplers, and other surgical instruments under the Weck, MiniLap, Pleur-Evac, Deknatel, KMedic, Pilling, and Titan SGS brands. It serves hospitals, healthcare providers, and medical device manufacturers. The company also sells its products online. Teleflex Incorporated was incorporated in 1943 and is headquartered in Wayne, Pennsylvania.